Both IL-12 and IL-23 became a major focus for therapeutic intervention when elevated expression of IL12p40 was observed in autoimmune disorders (Fassbender et al., 1998; Shigehara et al., 2003). This evidence concerns the gene IL23A and autoimmune disease.